Profil
Mr. William Pang is on the Board of Directors at mimiX Biotherapeutics Ltd.
Mr. Pang was previously employed as an Asia Research Director by Capital International, Inc. (Investment Management Singapore), an Equity Analyst by Pyramis Global Advisors (Hong Kong) Ltd., an Investment Manager by ING Investment Management Asia Pacific (Hong Kong) Ltd., and a Fund Manager & Research Analyst by NNIP Advisors BV.
Postes actifs de William Pang
| Sociétés | Poste | Début |
|---|---|---|
Mimix Biotherapeutics Sàrl
Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Develops bio-fabrication technologies to enable tissue manufacturing for therapeutic and diagnostic purposes | Directeur/Membre du Conseil | - |
Anciens postes connus de William Pang
| Sociétés | Poste | Fin |
|---|---|---|
ING Investment Management Asia Pacific (Hong Kong) Ltd.
ING Investment Management Asia Pacific (Hong Kong) Ltd. Investment ManagersFinance INGIM-HK specializes in Asian markets, managing investments in close relationship with the parent group and the other Asian offices. The parent company INGIM is an active, long-term investment manager. In-depth research informs investment decisions and is a composite of proprietary quantitative models and internal fundamental analysis complemented by third-party inputs. The Hong-Kong office comprises three specialist teams, each contributing their expertise to the other Asian offices and to the parent group. The quantitative team builds strategic and tactical asset allocation models. The equity team defines the equity and real estate investment outlook for the region, while the fixed income team analyses the fixed-income outlook. The investment process starts with a mid-term macroeconomic view which determines asset allocation. Equity investments follow a growth-oriented approach and proceed from a bottom-up stock selection process focused on earnings momentum. Fixed-income investments follow a top-down approach focused on relative value to the market. The performance of Asian equity funds is measured against MSCI indexes; the performance of Asian fixed-income funds is measured against JPMorgan indexes. Decisions processes are team-based with individual accountability. | Gestionnaire de Portefeuille-Actions | 01/08/2012 |
Goldman Sachs Advisors BV
Goldman Sachs Advisors BV Investment ManagersFinance GSBV is an active investor which seeks to bring technical and analytical expertise in developing rigorous and superior solutions for clients and funds seeking more quantitative or model-driven solutions. The firm applies their proprietary research and analytics, global resources, portfolio diagnostics and risk management to the development of investment products and solutions in pursuit of their clients’ objectives. Top-down macro themes shape over-all strategy and provide the context for their bottom-up security selection. | Analyst-Equity | 01/01/2011 |
Capital International, Inc. (Investment Management Singapore)
Capital International, Inc. (Investment Management Singapore) Investment ManagersFinance Capital IM-SG is an active manager which follows a bottom-up investment approach based on fundamental research primarily performed in-house, with regular contacts with senior company management as the cornerstone. They accommodate the specific socially responsible investment preferences of their clients. The firm focuses on emerging economies in the Asia Pacific region, and pays specific attention to countries such as Vietnam, China and Thailand. Capital IM-SG has expertise in the non-renewable energy sector. They construct diversified portfolios and emphasize individual stock selection as the most critical factor in their investment process. | Directeur de la Recherche - Actions | - |
Pyramis Global Advisors (Hong Kong) Ltd.
Pyramis Global Advisors (Hong Kong) Ltd. Investment ManagersFinance Pyramis-Hong Kong is an active multiclass manager which utilizes traditional long-only, alternative equity and fixed-income investment strategies. The firm employs a fully integrated, comprehensive approach to investment management including diversified portfolio management teams, independent, diversified sources of alpha, rigorous and disciplined fundamental and quantitative research, a proprietary portfolio risk management platform and a dedicated equity trading operation built on leading-edge technology. | Analyst-Equity | 01/07/2015 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Goldman Sachs Advisors BV
Goldman Sachs Advisors BV Investment ManagersFinance GSBV is an active investor which seeks to bring technical and analytical expertise in developing rigorous and superior solutions for clients and funds seeking more quantitative or model-driven solutions. The firm applies their proprietary research and analytics, global resources, portfolio diagnostics and risk management to the development of investment products and solutions in pursuit of their clients’ objectives. Top-down macro themes shape over-all strategy and provide the context for their bottom-up security selection. | Finance |
ING Investment Management Asia Pacific (Hong Kong) Ltd.
ING Investment Management Asia Pacific (Hong Kong) Ltd. Investment ManagersFinance INGIM-HK specializes in Asian markets, managing investments in close relationship with the parent group and the other Asian offices. The parent company INGIM is an active, long-term investment manager. In-depth research informs investment decisions and is a composite of proprietary quantitative models and internal fundamental analysis complemented by third-party inputs. The Hong-Kong office comprises three specialist teams, each contributing their expertise to the other Asian offices and to the parent group. The quantitative team builds strategic and tactical asset allocation models. The equity team defines the equity and real estate investment outlook for the region, while the fixed income team analyses the fixed-income outlook. The investment process starts with a mid-term macroeconomic view which determines asset allocation. Equity investments follow a growth-oriented approach and proceed from a bottom-up stock selection process focused on earnings momentum. Fixed-income investments follow a top-down approach focused on relative value to the market. The performance of Asian equity funds is measured against MSCI indexes; the performance of Asian fixed-income funds is measured against JPMorgan indexes. Decisions processes are team-based with individual accountability. | Finance |
Capital International, Inc. (Investment Management Singapore)
Capital International, Inc. (Investment Management Singapore) Investment ManagersFinance Capital IM-SG is an active manager which follows a bottom-up investment approach based on fundamental research primarily performed in-house, with regular contacts with senior company management as the cornerstone. They accommodate the specific socially responsible investment preferences of their clients. The firm focuses on emerging economies in the Asia Pacific region, and pays specific attention to countries such as Vietnam, China and Thailand. Capital IM-SG has expertise in the non-renewable energy sector. They construct diversified portfolios and emphasize individual stock selection as the most critical factor in their investment process. | Finance |
Pyramis Global Advisors (Hong Kong) Ltd.
Pyramis Global Advisors (Hong Kong) Ltd. Investment ManagersFinance Pyramis-Hong Kong is an active multiclass manager which utilizes traditional long-only, alternative equity and fixed-income investment strategies. The firm employs a fully integrated, comprehensive approach to investment management including diversified portfolio management teams, independent, diversified sources of alpha, rigorous and disciplined fundamental and quantitative research, a proprietary portfolio risk management platform and a dedicated equity trading operation built on leading-edge technology. | Finance |
Mimix Biotherapeutics Sàrl
Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Develops bio-fabrication technologies to enable tissue manufacturing for therapeutic and diagnostic purposes | Health Technology |
















